Published in Physiol Rev on July 01, 2011
Transglutaminase factor XIII promotes arthritis through mechanisms linked to inflammation and bone erosion. Blood (2014) 1.56
Coagulation factor XIIIa is inactivated by plasmin. Blood (2015) 1.41
Factor XIII B subunit polymorphisms and the risk of coronary artery disease. Int J Mol Sci (2015) 1.38
Monocyte-directed RNAi targeting CCR2 improves infarct healing in atherosclerosis-prone mice. Circulation (2013) 1.30
Transglutaminase regulation of cell function. Physiol Rev (2014) 1.28
Immunopathology of chronic rhinosinusitis. Allergol Int (2015) 1.28
Increased expression of factor XIII-A in patients with chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol (2013) 0.99
Regulation of the activities of the mammalian transglutaminase family of enzymes. Protein Sci (2012) 0.93
Vein graft failure. J Vasc Surg (2013) 0.88
Safety of Factor XIII Concentrate: Analysis of More than 20 Years of Pharmacovigilance Data. Transfus Med Hemother (2016) 0.87
In vivo near-infrared imaging of fibrin deposition in thromboembolic stroke in mice. PLoS One (2012) 0.85
Factor XIIIa-dependent retention of red blood cells in clots is mediated by fibrin α-chain crosslinking. Blood (2015) 0.85
Coagulation factor XIIIa substrates in human plasma: identification and incorporation into the clot. J Biol Chem (2014) 0.83
Therapeutic approaches for celiac disease. Best Pract Res Clin Gastroenterol (2015) 0.81
Lateral growth limitation of corneal fibrils and their lamellar stacking depend on covalent collagen cross-linking by transglutaminase-2 and lysyl oxidases, respectively. J Biol Chem (2013) 0.80
Protein cross-linking by chlorinated polyamines and transglutamylation stabilizes neutrophil extracellular traps. Cell Death Dis (2016) 0.77
Discovery of potent and specific dihydroisoxazole inhibitors of human transglutaminase 2. J Med Chem (2014) 0.77
Allosteric Inhibition of Factor XIIIa. Non-Saccharide Glycosaminoglycan Mimetics, but Not Glycosaminoglycans, Exhibit Promising Inhibition Profile. PLoS One (2016) 0.76
Evaluating factor XIII specificity for glutamine-containing substrates using a matrix-assisted laser desorption/ionization time-of-flight mass spectrometry assay. Anal Biochem (2014) 0.76
Chronic Rhinosinusitis and the Coagulation System. Allergy Asthma Immunol Res (2015) 0.76
Flow Cytometric Investigation of Classical and Alternative Platelet Activation Markers. EJIFCC (2013) 0.76
A biochemical network can control formation of a synthetic material by sensing numerous specific stimuli. Sci Rep (2015) 0.76
Endoplasmic reticulum stress activates transglutaminase 2 leading to protein aggregation. Int J Mol Med (2014) 0.76
Transglutaminase 2 in cartilage homoeostasis: novel links with inflammatory osteoarthritis. Amino Acids (2016) 0.76
Transglutaminases factor XIII-A and TG2 regulate resorption, adipogenesis and plasma fibronectin homeostasis in bone and bone marrow. Cell Death Differ (2017) 0.76
Factor XIII Deficiency and Thrombocytopenia Are Frequent Modulators of Postoperative Clot Firmness in a Surgical Intensive Care Unit. Transfus Med Hemother (2017) 0.75
Factor XIII and adipocyte biology. Blood (2014) 0.75
Leptospira Immunoglobulin-Like Protein B (LigB) Binds to Both the C-Terminal 23 Amino Acids of Fibrinogen αC Domain and Factor XIII: Insight into the Mechanism of LigB-Mediated Blockage of Fibrinogen α Chain Cross-Linking. PLoS Negl Trop Dis (2016) 0.75
Advances of Coagulation Factor XIII. Chin Med J (Engl) (2017) 0.75
The interaction between fibrinogen and zymogen FXIII-A2B2 is mediated by fibrinogen residues γ390-396 and the FXIII-B subunits. Blood (2016) 0.75
Cellular Factor XIIIA Transglutaminase Localizes in Caveolae and Regulates Caveolin-1 Phosphorylation, Homo-oligomerization and c-Src Signaling in Osteoblasts. J Histochem Cytochem (2015) 0.75
Nonclinical analysis of the safety, pharmacodynamics, and pharmacokinetics of plasma-derived human FXIII concentrate in animals. Pharmacol Res Perspect (2016) 0.75
Common FXIII and fibrinogen polymorphisms in abdominal aortic aneurysms. PLoS One (2014) 0.75
Revisiting the mechanism of coagulation factor XIII activation and regulation from a structure/functional perspective. Sci Rep (2016) 0.75
Factor XIII-A transglutaminase deficient mice show signs of metabolically healthy obesity on high fat diet. Sci Rep (2016) 0.75
Airway factor XIII associates with type 2 inflammation and airway obstruction in asthmatic patients. J Allergy Clin Immunol (2015) 0.75
Bombyx mori and Aedes aegypti form multi-functional immune complexes that integrate pattern recognition, melanization, coagulants, and hemocyte recruitment. PLoS One (2017) 0.75
Identification of a FXIIIA variant in human neuroblastoma cell lines. Int J Biochem Mol Biol (2013) 0.75
Proteome analysis of mast cell releasates reveals a role for chymase in the regulation of coagulation factor XIIIA levels via proteolytic degradation. J Allergy Clin Immunol (2016) 0.75
Genomic variants reveal differential evolutionary constraints on human transglutaminases and point towards unrecognized significance of transglutaminase 2. PLoS One (2017) 0.75
Systemic and intestinal levels of factor XIII-A: the impact of inflammation on expression in macrophage subtypes. J Gastroenterol (2015) 0.75
The oxidative modification of cellular fibrin-stabilizing factor. Dokl Biochem Biophys (2016) 0.75
Inhibition of Fibrinolysis by Coagulation Factor XIII. Biomed Res Int (2017) 0.75
Modification of the catalytic subunit of plasma fibrin-stabilizing factor under induced oxidation. Dokl Biochem Biophys (2017) 0.75
Screening Cleavage of Factor XIII V34X Activation Peptides by Thrombin Mutants: A Strategy for Controlling Fibrin Architecture. Biochim Biophys Acta (2017) 0.75
Cre/lox Studies Identify Resident Macrophages as the Major Source of Circulating Coagulation Factor XIII-A. Arterioscler Thromb Vasc Biol (2017) 0.75
Interaction of factor XIII subunits. Blood (2014) 1.12
New direct and indirect methods for the detection of cyclooxygenase 1 acetylation by aspirin; the lack of aspirin resistance among healthy individuals. Thromb Res (2013) 1.07
Factor XIII Deficiency. Semin Thromb Hemost (2009) 0.97
SRC-dependent outside-in signalling is a key step in the process of autoregulation of beta2 integrins in polymorphonuclear cells. Biochem J (2004) 0.93
Factor XIII Val34Leu variant protects against coronary artery disease. A meta-analysis. Thromb Haemost (2007) 0.90
Epigallocatechin-3-gallate and penta-O-galloyl-β-D-glucose inhibit protein phosphatase-1. FEBS J (2012) 0.85
Three novel mutations in the glycoprotein IIb gene in a patient with type II Glanzmann thrombasthenia. Haematologica (2007) 0.84
Severe bleeding complications caused by an autoantibody against the B subunit of plasma factor XIII: a novel form of acquired factor XIII deficiency. Blood (2008) 0.84
Interaction between homocysteine and lipoprotein(a) increases the prevalence of coronary artery disease/myocardial infarction in women: a case-control study. Thromb Res (2011) 0.84
Diazo transfer-click reaction route to new, lipophilic teicoplanin and ristocetin aglycon derivatives with high antibacterial and anti-influenza virus activity: an aggregation and receptor binding study. J Med Chem (2009) 0.83
Antithrombin deficiency and its laboratory diagnosis. Clin Chem Lab Med (2010) 0.83
Trombophilic screening for nonarteritic anterior ischemic optic neuropathy. Graefes Arch Clin Exp Ophthalmol (2005) 0.83
Thrombomodulin-dependent effect of factor VLeiden mutation on factor XIII activation. Thromb Res (2011) 0.83
Factor XIII and atherothrombotic diseases. Semin Thromb Hemost (2010) 0.82
Acquired haemophilia: an often overlooked cause of bleeding - experience from a Hungarian tertiary care centre. Blood Coagul Fibrinolysis (2012) 0.81
Elevated factor XIII level and the risk of peripheral artery disease. Haematologica (2008) 0.81
Elevated factor XIII level and the risk of myocardial infarction in women. Haematologica (2007) 0.80
Palmarumycins BG1-BG7 and preussomerin BG1: establishment of their absolute configurations using theoretical calculations of electronic circular dichroism spectra. J Org Chem (2011) 0.80
Novel aspects of factor XIII deficiency. Curr Opin Hematol (2011) 0.80
Switch of voltage-gated K+ channel expression in the plasma membrane of chondrogenic cells affects cytosolic Ca2+-oscillations and cartilage formation. PLoS One (2011) 0.80
Factor XIII subunits in human tears; their highly elevated levels following penetrating keratoplasty. Clin Chim Acta (2010) 0.79
Binding of plasma factor XIII to thrombin-receptor activated human platelets. Thromb Haemost (2009) 0.79
Tetrodotoxin blocks L-type Ca2+ channels in canine ventricular cardiomyocytes. Pflugers Arch (2012) 0.79
Cleavage of factor XIII by human neutrophil elastase results in a novel active truncated form of factor XIII A subunit. Thromb Haemost (2008) 0.78
Coagulation factor XIII serves as protein disulfide isomerase. Thromb Haemost (2009) 0.78
Thrombomodulin-dependent effect of factor V Leiden mutation on the cross-linking of α2-plasmin inhibitor to fibrin and its consequences on fibrinolysis. Thromb Res (2012) 0.78
[Frequency of hyperhomocysteinemia in hemodialysis patients with folic acid supplementation]. Orv Hetil (2002) 0.78
Recurrent arterial thrombosis associated with the antithrombin basel variant and elevated lipoprotein(a) plasma level in an adolescent patient. J Pediatr Hematol Oncol (2012) 0.77
Direct thrombin inhibitors and factor xa inhibitors can influence the diluted prothrombin time used as the initial screen for lupus anticoagulant. Arch Pathol Lab Med (2013) 0.77
Dynamic properties of the native free antithrombin from molecular dynamics simulations: computational evidence for solvent- exposed Arg393 side chain. J Biomol Struct Dyn (2014) 0.76
The superiority of anti-FXa assay over anti-FIIa assay in detecting heparin-binding site antithrombin deficiency. Am J Clin Pathol (2013) 0.76
Synthesis, regioselective hydrogenolysis, partial hydrogenation, and conformational study of dioxane and dioxolane-type (9'-anthracenyl)methylene acetals of sugars. Carbohydr Res (2009) 0.76
Pituitary adenylate cyclase-activating polypeptide (PACAP) signalling enhances osteogenesis in UMR-106 cell line. J Mol Neurosci (2014) 0.76
The combined effect of fibrin formation and factor XIII A subunit Val34Leu polymorphism on the activation of factor XIII in whole plasma. Biochim Biophys Acta (2006) 0.76
Tetrodotoxin blockade on canine cardiac L-type Ca²⁺ channels depends on pH and redox potential. Mar Drugs (2013) 0.76
Synthesis and anticoagulant activity of bioisosteric sulfonic-Acid analogues of the antithrombin-binding pentasaccharide domain of heparin. Chemistry (2012) 0.76
Management and outcome of pregnancies in women with antithrombin deficiency: a single-center experience and review of literature. Blood Coagul Fibrinolysis (2015) 0.76
Selectivity problems with drugs acting on cardiac Na⁺ and Ca²⁺ channels. Curr Med Chem (2013) 0.76
Progressive chromogenic anti-factor Xa assay and its use in the classification of antithrombin deficiencies. Clin Chem Lab Med (2014) 0.75
Three novel germ-line VHL mutations in Hungarian von Hippel-Lindau patients, including a nonsense mutation in a fifteen-year-old boy with renal cell carcinoma. BMC Med Genet (2013) 0.75
Factor XIII-A subunit Val34Leu polymorphism in fatal atherothrombotic ischemic stroke. Blood Coagul Fibrinolysis (2014) 0.75
Synthesis of disaccharide fragments of the AT-III binding domain of heparin and their sulfonatomethyl analogues. Carbohydr Res (2011) 0.75
[Accessibility of special clinical laboratory tests in Hungary]. Orv Hetil (2011) 0.75
[Activity of natural coagulation inhibitor proteins in the acute phase of ischaemic stroke]. Ideggyogy Sz (2005) 0.75
Coagulation: cascade! Lancet (2011) 0.75
Early onset of abdominal venous thrombosis in a newborn with homozygous type II heparin-binding site antithrombin deficiency. Blood Coagul Fibrinolysis (2017) 0.75
Expression of coagulation factor XIII subunit A in acute promyelocytic leukemia. Cytometry B Clin Cytom (2012) 0.75
Inherited factor V deficiency associated with a novel heterozygous missense mutation (p.G493R) in a patient with excessive surgical bleeding. Thromb Haemost (2009) 0.75
Factor XIII improves platelet adhesion to fibrinogen by protein disulfide isomerase-mediated activity. Thromb Res (2012) 0.75
Effects of ad hoc clopidogrel loading versus pre-treatment on P-selectin expression after coronary stent implantation. Platelets (2006) 0.75
Uncovering the genetic background of natural anticoagulant deficiencies: time to look behind the scenes. Pol Arch Intern Med (2017) 0.75
Vitamin B12 level in peripheral arterial disease. J Thromb Thrombolysis (2013) 0.75
A kinetic study on the reductive opening of the diphenylmethylene acetal in methyl 2,3-O-diphenylmethylene-α-L-rhamnopyranoside. Carbohydr Res (2011) 0.75
Factor XDebrecen: Gly204Arg mutation in factor X causes the synthesis of a non-secretable protein and severe factor X deficiency. Haematologica (2008) 0.75
Variant type Glanzmann thrombasthenia caused by homozygous p.724R>X mutation in beta3 integrin. Thromb Res (2010) 0.75
Temporarily successful eradication therapy in acquired haemophilia with high inhibitor titer: a case report with a new protocol. Thromb Haemost (2008) 0.75